Literature DB >> 2013147

Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.

M V Cohen1, M J Byrne, B Levine, T Gutowski, R Adelson.   

Abstract

BACKGROUND: Although specific guidelines for the treatment of hypercholesterolemia have been published, it is not known whether physicians treating patients likely to have lipid disorders have adopted the recommendations. METHODS AND
RESULTS: The approach of cardiologists to the treatment of hypercholesterolemia in a metropolitan teaching hospital was assessed by interviewing patients with chest pain who were admitted for coronary angiography in 1988-1989 and by measuring fasting blood lipid profiles. At 1 month and again 12-24 months later, patients were contacted by telephone to determine if there had been any changes in treatment. Of 95 patients evaluated, 81 had coronary artery disease. Only 17% of those with high levels of total cholesterol and/or low density lipoprotein cholesterol were being actively treated with diet and/or drugs. In the remaining patients, either lipid studies had not been done or abnormal results had not been addressed. There was little change in treatment approach during the month after the diagnostic procedure. Furthermore, the experience was similar in those patients subjected to coronary revascularization. One to 2 years after the initial intervention, 69 of the original study group could be contacted again. Although active dietary or pharmacological therapy was initiated in some individuals during this interval, it was stopped in others. Thirty-five percent of hypercholesterolemic patients were receiving targeted therapy.
CONCLUSIONS: Thus, only a small proportion of patients with documented coronary artery disease and hypercholesterolemia were being actively treated for their lipid disorder, suggesting that the published treatment guidelines have not yet been fully accepted. However, an encouraging improvement in frequency of treatment of hypercholesterolemia was documented during the 1-2-year observation period.

Entities:  

Mesh:

Year:  1991        PMID: 2013147     DOI: 10.1161/01.cir.83.4.1294

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Does a fixed physician reminder system improve the care of patients with coronary artery disease? A randomized controlled trial.

Authors:  C D Frances; P Alperin; J S Adler; D Grady
Journal:  West J Med       Date:  2001-09

2.  The clinical effect and tolerability of ezetimibe in high-risk patients managed in a specialty cardiovascular risk reduction clinic.

Authors:  Glen J Pearson; Gordon A Francis; Jacques S Romney; Dawna M Gilchrist; Andrea Opgenorth; Gabor T Gyenes
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

3.  Physician extenders for cost-effective management of hypercholesterolemia.

Authors:  G Schectman; N Wolff; J C Byrd; J G Hiatt; A Hartz
Journal:  J Gen Intern Med       Date:  1996-05       Impact factor: 5.128

4.  Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction.

Authors:  John Z Ayanian; Bruce E Landon; Mary Beth Landrum; James R Grana; Barbara J McNeil
Journal:  J Gen Intern Med       Date:  2002-02       Impact factor: 5.128

5.  Undertreatment of hypercholesterolaemia: a population-based study.

Authors:  A K Mantel-Teeuwisse; W M M Verschuren; O H Klungel; D Kromhout; A D Lindemans; J Avorn; A J Porsius; A de Boer
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

6.  Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.

Authors:  F J García Ruiz; A Marín Ibáñez; F Pérez-Jiménez; X Pintó; G Nocea; C Ahumada; E Alemao; D Yin
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 7.  Current concepts in secondary prevention after acute myocardial infarction.

Authors:  R H Mehta; E Bossone; K A Eagle
Journal:  Herz       Date:  2000-02       Impact factor: 1.443

Review 8.  The importance of lowering cholesterol in patients with coronary heart disease.

Authors:  D Eisenberg
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

9.  Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk.

Authors:  Ann Hiott Barham; David C Goff; Haiying Chen; Aarthi Balasubramanyam; Erica Rosenberger; Denise E Bonds; Alain G Bertoni
Journal:  Prev Cardiol       Date:  2009

10.  A comparison of self-report and chart audit in studying resident physician assessment of cardiac risk factors.

Authors:  D A Leaf; W E Neighbor; D Schaad; C S Scott
Journal:  J Gen Intern Med       Date:  1995-04       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.